NIFTY 500 › Fast Moving Consumer Goods
Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance
Guidance tracker
What ZYDUSWELL guided, and what came next
| Filed | What the filing says | Next results: profit YoY | Revenue | Move on the day |
|---|---|---|---|---|
| 07 Nov 2026 | Zydus Wellness filed the transcript of its Q2 FY2027 earnings conference call held on November 3, 2026. Management (CEO Tarun Arora) said consolidated net sales for Q2 FY27 were INR 11,227 million, up 74.6% year-on-year, and EBITDA was INR 855 million, up 271.7%. For the half year ended September 30, 2026, net... NSE copy | No results filed since | ||
| 22 May 2026 | Zydus Wellness filed the transcript of its Q4 FY2026 earnings conference call held on May 18, 2026. Management said Q4 net sales grew 62.1% and FY26 net sales grew 46.4%, with international (including Comfort Click) like-to-like growth of 31.4% in Q4 and 29.5% for FY26, and domestic growth of 1.7% in Q4 and 2.4%... NSE copy | -7.0 % | +66.9 % | -3.6 % |
| 09 Feb 2026 | Zydus Wellness filed the transcript of its Q3 FY2026 earnings conference call held on February 3, 2026. Management said consolidated net sales grew 113.7% year-on-year in Q3 FY26, with Food & Nutrition up 134% and Personal Care down 1.4%; consolidated EBITDA was INR610 million, with EBITDA margin of 6.3% versus... NSE copy | - | - | +2.7 % |
| 05 Aug 2025 | Zydus Wellness filed the transcript of its Q1 FY2026 earnings conference call held on July 30, 2025. Management said consolidated net sales grew 2.2% to Rs. 8,577 million; excluding seasonal brands, growth was double-digit, and organic volume and value growth was near flattish including seasonal brands. Management... NSE copy | -352.6 % | +32.0 % | -4.1 % |
| 23 May 2025 | Zydus Wellness filed the transcript of its Q4 FY2025 earnings conference call held on May 19, 2025, under Regulations 30 and 46(2)(oa)(iii) of the SEBI Listing Regulations. Management said Q4 consolidated net sales grew 17% to INR 9,106 million, with volume growth of 13%; FY2025 net sales grew 16.2% to INR 26,912... NSE copy | -13.4 % | +2.4 % | -1.2 % |
| 10 Feb 2025 | Zydus Wellness filed the transcript of its Q3 FY2025 earnings conference call held on February 4, 2025, under Regulations 30 and 46(2)(oa)(iii) of the SEBI LODR Regulations. Management said consolidated net sales grew 12.7% to INR 4,508 million, with volume growth of 4.8% year-on-year, and EBITDA grew 16.5%... NSE copy | -13.4 % | +2.4 % | -1.2 % |
Filings tagged as guidance, newest first (6 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.
Governance
Management, auditors, ratings and legal matters
| Filed | Kind | What the filing says |
|---|---|---|
| 02 Sep 2026 | Management change | Zydus Wellness filed the transcript of its 32nd Annual General Meeting, held virtually on August 4, 2026 (10:00 to 10:48 A.M. IST). Chairman Dr. Sharvil P. Patel said revenue from operations rose 46.2% to Rs. 36,610 million in FY26 and EBITDA grew 34.2% to Rs. 5,097 million, with seasonal brands hit by delayed... NSE copy |
| 19 Aug 2026 | Credit rating | Zydus Wellness Limited intimated that CARE Ratings Limited has assigned a credit rating to long-term bank facilities of Zydus Wellness Products Limited, a wholly owned material subsidiary. Rated long-term bank facilities amount: ₹12.00 crore; rating: CARE AA+; Stable (assigned). The intimation was received by email... NSE copy |
| 10 Nov 2025 | Legal or regulatory | Zydus Wellness filed the transcript of its Q2 FY2026 earnings conference call held on November 5, 2025. Management said consolidated net sales grew 31% for the quarter and 12.8% for H1 FY26, driven by newly acquired entities, offsetting seasonal product pressure; consolidated EBITDA was INR230 million, up 17.3%... NSE copy |
| 19 May 2025 | Legal or regulatory | Board of Zydus Wellness Limited recommended a final dividend of ₹6.00 per equity share (60% on ₹10 face value), subject to members' approval at the AGM on July 30, 2025; record date is Friday, July 11, 2025, and payment on or after August 4, 2025. Board proposed sub-division of equity shares: 1 equity share of ₹10... NSE copy |
Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (4 in all). A list of what was filed, not a judgement of the company.